These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 18176193)

  • 1. Rituximab and desensitization for a patient with severe factor IX deficiency, inhibitors, and history of anaphylaxis.
    Alexander S; Hopewell S; Hunter S; Chouksey A
    J Pediatr Hematol Oncol; 2008 Jan; 30(1):93-5. PubMed ID: 18176193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of immune tolerance using rituximab in a child with severe haemophilia B with inhibitors and anaphylaxis to factor IX.
    Barnes C; Davis A; Furmedge J; Egan B; Donnan L; Monagle P
    Haemophilia; 2010 Sep; 16(5):840-1. PubMed ID: 20546030
    [No Abstract]   [Full Text] [Related]  

  • 3. Desensitization and immune tolerance induction in children with severe factor IX deficiency; inhibitors and adverse reactions to replacement therapy: a case-report and literature review.
    Bon A; Morfini M; Dini A; Mori F; Barni S; Gianluca S; de Martino M; Novembre E
    Ital J Pediatr; 2015 Feb; 41():12. PubMed ID: 25887512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of rituximab as an adjuvant for immune tolerance therapy in a hemophilia B boy with inhibitor and anaphylaxis to factor IX concentrate.
    Chuansumrit A; Moonsup Y; Sirachainan N; Benjaponpitak S; Suebsangad A; Wongwerawattanakoon P
    Blood Coagul Fibrinolysis; 2008 Apr; 19(3):208-11. PubMed ID: 18388500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab in the treatment of alloimmune factor VIII and IX antibodies in two children with severe haemophilia.
    Mathias M; Khair K; Hann I; Liesner R
    Br J Haematol; 2004 May; 125(3):366-8. PubMed ID: 15086418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful eradication of inhibitor in a patient with severe haemophilia B and anaphylaxis to factor IX concentrates: is there a role for Rituximab and desensitization therapy?
    Gamerman S; Singh AM; Makhija M; Sharathkumar A
    Haemophilia; 2013 Nov; 19(6):e382-5. PubMed ID: 23992223
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibitors in factor IX deficiency a report of the ISTH-SSC international FIX inhibitor registry (1997-2006).
    Chitlur M; Warrier I; Rajpurkar M; Lusher JM
    Haemophilia; 2009 Sep; 15(5):1027-31. PubMed ID: 19515028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful second ITI with factor IX and combined immunosuppressive therapy. A patient with severe haemophilia B and recurrence of a factor IX inhibitor.
    Holstein K; Schneppenheim R; Schrum J; Bokemeyer C; Langer F
    Hamostaseologie; 2014; 34 Suppl 1():S5-8. PubMed ID: 25382771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of anaphylactic shock in haemophilia B patients with inhibitors.
    Warrier I; Lusher JM
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S125-8. PubMed ID: 9819043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Achievement of immune tolerance in a patient with haemophilia B and inhibitory antibodies, complicated by an anaphylactoid reaction.
    Curry NS; Misbah SA; Giangrande PL; Keeling DM
    Haemophilia; 2007 May; 13(3):328-30. PubMed ID: 17498084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors in haemophilia B: the Italian experience.
    Castaman G; Bonetti E; Messina M; Morfini M; Rocino A; Scaraggi FA; Tagariello G;
    Haemophilia; 2013 Sep; 19(5):686-90. PubMed ID: 23601006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of inhibitors.
    Astermark J
    Semin Hematol; 2006 Apr; 43(2 Suppl 4):S3-7. PubMed ID: 16690373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of immune tolerance and suppression of anaphylaxis in a child with haemophilia B by simple plasmapheresis and antigen exposure.
    Barnes C; Rudzki Z; Ekert H
    Haemophilia; 2000 Nov; 6(6):693-5. PubMed ID: 11122398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of factor IX inhibitor development in severe haemophilia B patients treated with only one brand of high purity plasma derived factor IX concentrate.
    Parquet A; Laurian Y; Rothschild C; Navarro R; Guérois C; Gay V; Durin A; Peynet J; Sultan Y
    Thromb Haemost; 1999 Oct; 82(4):1247-9. PubMed ID: 10544907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of a recombinant factor IX (Bax326) in previously treated patients with severe or moderately severe haemophilia B undergoing surgical or other invasive procedures: a prospective, open-label, uncontrolled, multicentre, phase III study.
    Windyga J; Lissitchkov T; Stasyshyn O; Mamonov V; Ghandehari H; Chapman M; Fritsch S; Wong WY; Pavlova BG; Abbuehl BE
    Haemophilia; 2014 Sep; 20(5):651-8. PubMed ID: 24697870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eradication of factor IX neutralizing and anaphylactic inhibitors in a patient with severe haemophilia B using cyclophosphamide immune suppression and factor IX desensitization.
    Greenmyer JR; Grindeland CJ; Kobrinsky NL
    Haemophilia; 2020 Mar; 26(2):e51-e54. PubMed ID: 31961035
    [No Abstract]   [Full Text] [Related]  

  • 17. [Factor IX inhibitor in hemophilia B presented with anaphylactoid symptoms: report of 3 cases].
    Taketani T; Hanada R; Kawaguchi H; Ida K; Yamamoto K
    Rinsho Ketsueki; 1999 Oct; 40(10):1124-6. PubMed ID: 10565232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitor development in haemophilia B: an orphan disease in need of attention.
    DiMichele D
    Br J Haematol; 2007 Aug; 138(3):305-15. PubMed ID: 17614818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current management of hemophilia B: recommendations, complications and emerging issues.
    Franchini M
    Expert Rev Hematol; 2014 Oct; 7(5):573-81. PubMed ID: 25112898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab for adolescents with haemophilia and high titre inhibitors.
    Fox RA; Neufeld EJ; Bennett CM
    Haemophilia; 2006 May; 12(3):218-22. PubMed ID: 16643204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.